Cancer Researcher in a Lifelong Quest (Thailand)
This article was originally published in PharmAsia News
Dr. Arkom Cheirsilpa was recently honored with the Eminent Scientist 2007 Asia Award for his work in cancer prevention and treatment. Dr. Cheirsilpa is currently the deputy director for Thailand's National Cancer Institute (NCI). His award-winning efforts have focused on encouraging the wider use of inexpensive chemotherapy alternatives. Thanks to his research, Thai cancer patients have better access to a number of low-cost, cancer-fighting drugs that also offer fewer side-effects. Cheirsilpa has also done much to help the NCI better educate the country about cancer prevention and early detection. The Eminent Scientist Asia Award is presented annually by the International Research Promotion Council, a UK-based organization dedicated to furthering scientific advances in developing Asia-Pacific nations. (Click here for more
You may also be interested in...
The EU pharmaceutical strategy published on 25 November will be the first step in a “complete overhaul” of the medicines legislative framework to be proposed in about two years’ time, says the European Commission.
The European Commission’s newly-published Pharmaceutical Strategy features a range of proposals related to generics and biosimilars, including “targeted policies” to improve competition, remove barriers and increase uptake.
Pfizer’s efforts to circumvent two US patents shielding Par’s Adrenalin (epinephrine) have again ended in failure, following a ruling by the US Court of Appeals for the Federal Circuit.